Researchers have identified that a certain immune cell can change characteristics after a stem cell transplant, contributing to graft versus host disease (GvHD).
Type II innate lymphoid cells (ILC2) often fail to be generated by donor cells and se...
1 year ago
Toxicity monitoring periods could be halved for patients who receive CAR-T therapy for diffuse large B-cell lymphoma (DLBCL), according to a new study.
The treatment is associated with two serious side-effects, cytokine release syndrome (CRS) and...
1 year ago
